It wasn't the "one dollar" Banting had dreamed of, but for the first time in months, Elias didn't have to choose between his medicine and his meals. He handed over his card, the transaction went through, and he walked out into the sunlight. The clock on the counter had stopped ticking, at least for another thirty days.
"With the new state cap," Sarah explained, referencing a recent shift in California law to produce affordable insulin, "it's down to about $35 for the month". insulin to buy
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more 100 Years of Insulin - FDA It wasn't the "one dollar" Banting had dreamed
He grabbed his jacket and headed to the local pharmacy. He had heard about a new program, GetInsulin.org, that helped people find "action plans" based on their income and insurance. He had spent the morning filling out forms, hoping he wouldn't "fall through the cracks" like so many others. "With the new state cap," Sarah explained, referencing
Elias let out a dry laugh. It didn't feel like it belonged to him.
He logged into his bank portal. The balance blinked back at him—a number that didn’t quite cover both the rent due on Friday and the "list price" of the insulin he needed. In 1923, the men who discovered this hormone, Frederick Banting and his team, sold the patent for just one dollar. Banting had said, "Insulin belongs to the world".
At the counter, the pharmacist, Sarah, gave him a sympathetic look. "Your insurance denied the brand-name analog again, Elias," she said softly. "But they’ve started covering a biosimilar now—it’s called Semglee. It works just like the Lantus you’re used to, but it’s significantly cheaper". Elias felt a surge of relief. "How much cheaper?"